Apomorphine in malignant syndrome due to levodopa withdrawal

U Bonuccelli; P Piccini; G U Corsini; A Muratorio

doi:10.1007/BF02226968

Apomorphine in malignant syndrome due to levodopa withdrawal

Ital J Neurol Sci. 1992 Mar;13(2):169-70. doi: 10.1007/BF02226968.

Authors

U Bonuccelli¹, P Piccini, G U Corsini, A Muratorio

Affiliation

¹ Clinica Neurologica, Università di Pisa.

PMID: 1592579
DOI: 10.1007/BF02226968

Abstract

We report a case of neuroleptic malignant syndrome (NMS) following abrupt reduction of chronic levodopa treatment in a 71 year old female parkinsonian patient. The NMS resolved within 24 hours of the addition of apomorphine to levodopa therapy.

Publication types

Case Reports

MeSH terms

Aged
Apomorphine / therapeutic use*
Female
Humans
Levodopa / adverse effects*
Levodopa / therapeutic use
Neuroleptic Malignant Syndrome / drug therapy*
Parkinson Disease / complications
Parkinson Disease / drug therapy
Substance Withdrawal Syndrome / drug therapy*

Substances

Levodopa
Apomorphine